Alternative testing methods of radiopharmaceuticals in Czech Pharmacopoeia 2017 – Supplement 2021
Authors:
Jiří Štěpán
Authors place of work:
KRNM FN Brno a LF MU, Brno, ONM Uherskohradišťská nemocnice a. s., Uherské Hradiště, ČR
Published in the journal:
NuklMed 2022;11:49-57
Category:
Review Article
Summary
Introduction: A new general monograph Alternative testing methods of radiopharmaceuticals has been published in Czech Pharmacopoeia 2017 – Supplement 2021. As these many other methods for a radiochemical purity (RCP) measurement are pharmacopoeial, they can be officially directly used in radiopharmaceuticals workplaces of medical establishments without a prior validation. A purpose of this article is to acquaint workers with mentioned methods and to emphasize an importance of a use of a pharmacopoeial recommended stationary phase in chromatography to achieve appropriate results on example of a frequent radiopharmaceutical [99mTc]-oxidronate.
Method: A tabular statement of chromatographic methods for the radiochemical purity measurement of individual radiopharmaceuticals with supplement of desired values of the radiochemical purity and a calculation of the radiochemical purity in a case of more impurities. A paper radiochromatography using a scanner of chromatographic strips PT444R1. A radiopharmaceutical: [99mTc]-oxidronate, a mobile phase: 0,9% NaCl, stationary phases: TLC-SP, 3MM Chr, 1 Chr (9 x 1 cm), a path length was 7 cm. A developed and scanned chromatogram was evaluated by software of the scanner.
Results: Tables summarizing chromatographic methods for the radiochemical purity measurement of the radiopharmaceuticals including the required values of the radiochemical purity and calculating formulas. A comparison of a distribution of [99mTc]-oxidronate on TLC-SP, 3MM Chr, 1 Chr chromatograms revealed a regular chromatographic separation only on a chromatographic paper TLC-SP (Supelco™) recommended by the pharmacopoeia.
Conclusion: Stated chromatographic methods for the radiochemical purity measurement of the radiopharmaceuticals can be directly used instead of the ones stated for example in summaries of product characteristics (SPCs), which needn‘t be available in the workplace, such as an electrophoresis, a membrane filtration etc. An importance of a use of a specific commercial source of a chromatographic carrier resulted from an example of a [99mTc]-oxidronate chromatography as using an other one doesn‘t ensure its availability and a responsible person is responsible for a confirmation of a suitability of other commercial brand of an adequate quality.
Keywords:
colloidal technetium-99m – pertechnetate-(99mTc) – bound technetium-99m – radiochemical purity – radiochemical impurities – [99mTc]technetium-oxidronate
Zdroje
- Vyhláška č. 84 ze dne 11. března 2008 o správné lékárenské praxi, bližších podmínkách zacházení s léčivy v lékárnách, zdravotnických zařízeních a u dalších provozovatelů a zařízení vydávajících léčivé přípravky [online]. 2008. [cit. 2022-06-13]. Dostupné na: <https://www.zakonyprolidi.cz/cs/2008-84?text=84%2F2008>
- Zahrádka F. Přehled kontrolních metod pro kity dodávané firmou KC SOLID, spol. s r. o. – včetně alternativních provedení. 1. vyd. Rokycany, KC SOLID, spol. s r. o., 2009, 2 p
- The International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH: Q 2 (R1): Validation of analytical procedures: Text and methodology - Step 5 [online]. Q2(R1) version. Amsterdam, European Medicines Agency (EMA), November 2005 [cit. 2022-06-13], 15 p. Dostupné na: < https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures>
- World Health Organization. The International Pharmacopoeia [online]. 10th ed. Geneva, WHO, 2020 [cit. 2022-06-13]. Dostupné na: <https://digicollections.net/phint/2020/index.html#p/home>
- Ministerstvo zdravotnictví ČR. Český lékopis 2017 – Doplněk 2021: elektronická verze vč. všech doplňků [online E-kniha]. Praha, Grada, 2021 [cit. 2022-06-13]. Dostupné na: <https://www.grada.cz/cesky-lekopis-2017-doplnek-2021-(1)-12031/>
- INPHARMEX, spol. s r.o. AISLP – verze v INTRANETU [online]. Verze 2022.2k, stav k 1. 5. 2022. Praha, INPHARMEX, 2022 [cit. 2022-06-13]. Dostupné na: <https://www.aislp.cz/>
- ZOLLE I ed. Technetium-99m Pharmaceuticals: Preparation and Quality Control in Nuclear Medicine. 1st edition. Berlin; Heidelberg; New York, Springer, 2007, 345 p
- The United States Pharmacopeial Convention. United States Pharmacopeia and National Formulary (USP43-NF38). Baltimore, MD: United Book Press, Inc., 2019, 8759 p
- Zea-Ponce Y, Baldwin RM, Zoghbi SS, Innis RB. Formation of I-[1231]Iodobutane in Labeling [123I]Iomazenil by Iododestannylation: Implications for the Reaction Mechanism. Appl Radiat Isot 1994;45:63-68
- Hotte CE; Ice RD. Thermal and Radiolytic Decomposition of 131I-19-Iodocholesterol. J Nucl Med 1974;15:38–41
- Kocna P. Funkční dechové testy – neinvazivní diagnostika v gastroenterologii. Klin Biochem Metab 2021;29:3,124-131
- Beer HF, Bläuenstein PA, Hasler PH et al. In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990;31:1007–1014
- Ellis B, Ballinger J. Radiochemical purity testing [online]. Verze 3. Nottingham (UK), UKRG, May 2021 [cit. 2022-06-13]. Dostupné na: <https://cdn.ymaws.com/www.bnms.org.uk/resource/resmgr/ukrg/resources/2021_information_resources_r.pdf>
Štítky
Nuclear medicine Radiodiagnostics RadiotherapyČlánok vyšiel v časopise
Nuclear Medicine
2022 Číslo 3
Najčítanejšie v tomto čísle
- Brain SPECT in patients with cognitive disorders – comparison with clinical diagnosis and significance for clinical practise – still valid possiblity?
- Alternative testing methods of radiopharmaceuticals in Czech Pharmacopoeia 2017 – Supplement 2021
- 43. Pracovní dny Radiofarmaceutické sekce ČSNM, Strážnice
- PET pracoviště nemocnice Chomutov